Shareholders meeting

SATI PARENTERALS Date: 10.09.2026 The Manager The Manager, BSE Limited NSE Limited, P. J. Towers, Dalal Street Exchange Plaza, Bandra Kurla Complex, Mumbai-400001 Bandra (E), Mumbai- 400051. (BSE Scrip Code: 544742) (NSE Symbol: SAIPARENT) Dear Sir/ Madam, Sub: Outcome of 25" Annual General Meeting held on 10.09.2026. Unit: Sai Parenterals Limited With reference to the subject cited above, this is to inform the Exchanges that the 25% Annual General Meeting of Sai Parenterals Limited held on Thursday, 10* of September, 2026 at 11:14 A.M. through Video Conferencing (“VC”) / Other Audio-Visual Means (“OAVM”). In this regard, please find enclosed the following- 1) Summ: ary ooff p proceedinggs as reqqu ired under Regguul ation 30, Part-A of Schedule -IIT of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure — I. (2) Voting Results of the business transacted at the AGM held on Thursday, 10.09.2026 as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure —IT. (3) Report of Scrutinizer pursuant to Sec. 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014 as Annexure — ITI. The Meeting concluded at 12:05 p.m. (Excluding the Voting period). This is for the kind information and records of the Exchanges, please. Thanking you. Yours faithfully, For Sai Parenterals Limited Mr. Anil Kumar Karusala Managing Director (DIN- 01866646) SAIPARENTERALS www.saiparenterals.com Registered office : Plot No 39, 5th Floor, Lavanya Arcade, Jayabheri Enclave, Gachibowli, Hyderabad -500032. Email: infoasaiparontorals.com © 1917997991306 CIN:U24231762001PLCO36043 SATI PARENTERALS Annexure — 1 The Manager The Manager, BSE Limited NSE Limited, P. J. Towers, Dalal Street Exchange Plaza, Bandra Kurla Complex, Mumbai-400001 Bandra (E), Mumbai- 400051. (BSE Scrip Code: 544742) (NSE Symbol: SAIPARENT) Dear Sir/ Madam, Sub: Summary of Proceedings of 25 Annual General Meeting held on 10.09.2026 as required under Regulation 30, PART - A of the schedule III of the SEBI (Listing Obligations and Disclosure Requirements), 2015. Unit: Sai Parenterals Limited Summary of proceedings of the Annual General Meeting: The Annual General Meeting (AGM) of the Members of Sai Parenterals Limited (‘the Company’) held on Thursday, 10® September, 2026 at 11:14 A.M (IST) through Video conference /Other audio- visual means, in compliance with the General Circulars issued by the Ministry of Corporate Affairs (MCA) and circulars issued by the Securities and Exchange Board of India (SEBI) in this regard and as per the applicable provisions of the Companies Act, 2013 and the Rules made thereunder. Directors and KMP present (all present through VC): S. No Name Designation 1. Anil Kumar Karusala Managing Director & Chairperson 2. Vijitha Gorrepati ‘Whole Time Director 3. Kunal Kakumanu Executive Director 4. Seeta Ram Anjaneyulu Gorantla Independent Director 5. Bhagyashri Dharmasa Zad Independent Director 6. Kalidindi V Raju Independent Director 7. Anil Kumar Chief Financial Officer 8. D B Venkoji Prakash Chief Executive Officer 9. Shivali Aggarwal Company Secretary and Compliance Officer Other Invitees in attendance (all present through VC): S. No Name Designation 1. M/s. R Kabra & Co. LLP Statutory Auditors 2. M/s. NSVR & Associates LLP Internal Auditors 3. M/s. Aakanksha Dubey & Co. Secretarial Auditor & Scrutinizer SAIPARENTERALS www.saiparenterals.com Registered office : Plot No 39, 5th Floor, Lavanya Arcade, Jayabheri Enclave, Gachibowli, Hyderabad -500032. Email: infoasaiparontorals.com © 1917997991306 CIN:U24231762001PLCO36043 SATI PARENTERALS Quorum of the meeting: A total of 54 members attended the meeting through VC. The meeting commenced at 11:14 A.M. (IST) and concluded at 12:05 PM. (IST) (Excluding time allowed for e- voting at AGM). Proceedings of the Meeting: Ms. Shivali Aggarwal, Company Secretary has initialed the process of meeting with a welcome to the members of the Company and introduced the Chairman and other members of the Board to the 25% Annual General Meeting held through Video conference. Also introduced Statutory Auditors and Secretarial Auditors to the Annual General Meeting held through video conference. Mr. Anil Kumar Karusala, Managing Director and Chairman of the Board chaired the meeting. The Chairman extended a warm welcome to all members, auditors and other invitees who joined the meeting through VC. He confirmed that the Company had taken all feasible efforts under the current circumstances to enable members to participate through VC and vote on the items being considered for the meeting. After ascertaining that the requisite quorum was present, the Chairman called the meeting to order. The Chairman addressed the Members and apprised them of the key highlights of the Company’s financial performance, significant milestones achieved, major investments undertaken during the financial year ended March 31, 2026, and the Company’s outlook and expected performance for the financial year 2026-27. The Chairman thereafter took the Notice of AGM and Board’s Report as read. With the permission of the Chairman, the Company Secretary proceeded with the agenda and informed the members about the procedure to be followed for voting during the AGM, then read out the following items of business, as per the Notice of AGM: S. Description of Resolutions Type of No resolution 1. To receive, consider and adopt the Audited Balance Sheet as at March 31%, | Ordinary 2026, the Statement of Profit & Loss and Cash Flow Statement, (Standalone and consolidated) for the year ended on that date together with the Notes attached thereto, along with the Reports of Auditors and Directors thereon. 2. | To appoint a director in place of Mr. Anil Kumar Karusala (DIN: 01866646) | Ordinary who retires by rotation and being eligible, offers himself for re-appointment. 3. | Re-appointment of Mr. Anil Kumar Karusala (DIN: 01866646) as Managing Special Director of the company. 4. | Re-Appointment Of Mrs. Vijitha Gorrepati (DIN: 03492979) As Whole-Time Special Director of the company. 5. | To appoint Mr. Kunal Kakumanu (DIN:11281388) as an Executive Director of Special the Company. 6. | To appoint M/s. Aakanksha Dubey & Co., Practicing Company Secretaries as | Ordinary secretarial auditors for a term of up to 5 (Five) Consecutive Years. SAIPARENTERALS www.saiparenterals.com Registered office : Plot No 39, 5th Floor, Lavanya Arcade, Jayabheri Enclave, Gachibowli, Hyderabad -500032. Email: infoasaiparontorals.com (© 1917997991206 CIN:U24231762001PLCO36043 SATI PARENTERALS 7. | Variation in the objects and/or terms of utilisation of the IPO Proceeds and Special extension of the time period for utilisation of the IPO Proceeds as disclosed in the prospectus dated march 28, 2026, relating to Objects (A) Capacity Expansion and Upgradation of Manufacturing Facilities and (B) Establishment of a Research & Development Centre. 8. | Ratification of the Sai Parenteral’s Limited Employee Stock Option Plan 2025 Special (“Esop Scheme - 2025”) of the Company. 9. Ratification of the Extension of Benefits of the Sai Parenteral’s Limited Special Employee Stock Option Plan 2025 (“Esop Scheme - 2025”) to the Subsidiary Companies. 10. | To Consider and approve the Material Related Party Transaction of the | Ordinary Company in respect of the Grant of a Loan to Sai Singapore Pte. Ltd. for Downstream funding to Noumed Pharmaceuticals Pty. Limited, Australia. 11. | To approve Material Related Party Transactions of the Company with Noumed | Ordinary Pharmaceuticals Pty. Limited, Step-Down Subsidiary Company for the FY 2026-27. 12. | Ratification of Payment of Remuneration to the Cost Auditor for the Financial | Ordinary Year 2026-27. Since, all the Resolutions have been already put to vote through remote e-voting, there was no proposing and seconding of the Resolutions and no voting by show [Showing first 8,000 characters — download PDF for full document]